The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGunsynd Regulatory News (GUN)

Share Price Information for Gunsynd (GUN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.14
Bid: 0.13
Ask: 0.15
Change: 0.00 (0.00%)
Spread: 0.02 (15.385%)
Open: 0.14
High: 0.14
Low: 0.14
Prev. Close: 0.14
GUN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update for Rincon Resources

9 Nov 2022 07:00

RNS Number : 7525F
Gunsynd PLC
09 November 2022
 

Gunsynd plc

 

("Gunsynd" or the "Company")

 

Operational Update for Rincon Resources Limited

 

 

Gunsynd Plc (AIM: GUN, AQSE: GUN) is pleased to announce a positive operational update for one of its investee companies, Rincon Resources Limited ("Rincon") (ASX: RCR), an ASX listed Australian gold and base metals exploration company.

 

The Board of Gunsynd was very pleased to see that Rincon received a preliminary high-level report from independent consultant Resource Potentials highlighting the similarities between Rincon's Pokali Prospect and an exciting new Niobium Rare Earth (REE) discovery by WA1 Resources Limited (ASX: WA1) located about 87km NW of Pokali. The Pokali target is located within Rincon's 100% owned Kiwirrkurra IOCG Project, located in the West Arunta Region of Western Australia.

 

As well as being used in the steel industry predominantly as a micro alloy with iron, Niobium (Nb), along with other refractory elements such as tantalum, is also used in nickel and nickel iron superalloys, particularly for applications requiring strength and heat resistance. Uses for such superalloys include turbine blades in jet engines within the aeronautic industry, and gas turbines in the energy industry. Australia's niobium resource is confined to a small number of deposits, largely as a by-product or co-product of rare earth element (REE) or rare earth element-zirconium mineralisation in peralkaline rocks and carbonatites. Examples of these include the Mount Weld carbonatite and the Brockman deposits in Western Australia.

 

Rincon has reported that historical drilling and surface geochemical datasets over Pokali were interrogated however most historical activity and geological analysis was focused on IOCG-style copper mineralisation and REE assaying was limited. Therefore, Rincon will be implementing programmes to obtain new multi-element and REE data for analysis to further understand the REE potential of its Kiwirrkurra Project. Rincon has recently received a Consent to Mine endorsement and Ministerial Entry Permit for its granted tenements at the Kiwirrkurra Project, permitting on-ground exploration activities to commence. A site reconnaissance and rock-chip sampling programme will commence later this week at Pokali to investigate the potential for REE mineralisation at Pokali and other outcropping target areas to the east.

The work programme described above will be operated in conjunction with a 3,000m aircore drilling campaign and will test three priority targets along the highly prospective Hasties-Grace Trend, a major structural corridor known to host significant copper-gold mineralisation and which passes through all of Rincon's main Gold-Copper project areas, as announced on 13 October 2022. Targets to be tested with the forthcoming programme are located along strike and within 5km of Paterson Resources Limited's Grace-Bemm Deposit. 

As announced on 2 November 2022, Gunsynd's further investment of 2,165,812 shares at 8 AUD cents for a total consideration of AUD$173,265 had been approved by Rincon shareholders. Rincon intends to utilise the funds raised pursuant to the capital raising to explore its existing and proposed projects and for general working capital.

As a result, Gunsynd now holds 11,065,812 ordinary shares in Rincon representing approximately 16.37% of Rincon's issued share capital.

 

The Directors of Gunsynd accept responsibility for this announcement.

 

For further information please contact:

 

Gunsynd plc

Hamish Harris/ Peter Ruse

 

 

+44 (0) 78 7958 4153

Cairn Financial Advisers LLP

James Caithie / Liam Murray

 

+44 (0) 20 7213 0880

 

Peterhouse Capital Limited

Lucy Williams

 

+44 (0) 20 7469 0936

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDBPBBTMTMMTLT
Date   Source Headline
6th Dec 20129:57 amRNSForm 8.5 (EPT/NON-RI)
6th Dec 20127:00 amRNSApproval of Opening Position Disclosure
5th Dec 201211:11 amRNSForm 8.5 (EPT/NON-RI)
4th Dec 201211:53 amRNSForm 8.5 (EPT/NON-RI)
3rd Dec 201212:19 pmRNSForm 8.3 - [Evocutis PLC]
3rd Dec 20127:00 amRNSStrategic Review
3rd Dec 20127:00 amRNSFinal Results
23rd Nov 20127:00 amRNSNotice of Results
5th Nov 20127:00 amRNSIssue of Equity
21st Sep 20127:00 amRNSTR-1 Notification of Major Interest in Shares
8th Aug 201212:24 pmRNSUpdate on commencement of dealings
1st Aug 20127:00 amRNSIssue of Equity and Grant of Share Options
21st Jun 20127:00 amRNSTrading Update
30th Apr 20127:00 amRNSDirectorate Change
4th Apr 20127:00 amRNSDirectorate Change
22nd Mar 20127:00 amRNSInterim Results
29th Feb 20127:00 amRNSNotification of Results
27th Jan 20127:00 amRNSEvocutis validates anti-ageing LabSkinT model
24th Jan 20121:35 pmRNSResult of AGM
13th Jan 20127:00 amRNSEvocutis Opens State-of-the-art laboratory
23rd Dec 20117:00 amRNSDirector/PDMR Shareholding
15th Dec 20117:00 amRNSNotice of AGM and Report and Accounts
29th Nov 20117:00 amRNSPreliminary Results
28th Nov 20117:00 amRNSEvocutis launches antimicrobial LabSkinT model
20th Oct 20115:03 pmRNSResult of GM and Change of Name to Evocutis plc
30th Sep 20117:00 amRNSBusiness Update
27th Sep 20117:00 amRNSPosting of Circular and Notice of General Meeting
8th Jul 20117:00 amRNSChange of Registered Office
21st Jun 201111:00 amRNSDirectorate Change
23rd May 201111:45 amRNSResult of General Meeting
11th May 201111:17 amRNSDirector's Dealing
6th May 20117:00 amRNSAcquisition and Placing to raise £2 million
27th Apr 20112:30 pmRNSBusiness Update
8th Mar 20117:00 amRNSInterim Results
2nd Mar 20113:12 pmRNSHolding(s) in Company
25th Feb 20117:00 amRNSHolding(s) in Company
20th Jan 20111:23 pmRNSResult of AGM
17th Jan 20117:00 amRNSSyntopix to research biofilms for Beiersdorf AG
14th Jan 201110:13 amRNSPosting of Annual Report and notice of AGM
3rd Dec 20107:00 amRNSGrant of share options to Directors
29th Nov 20107:00 amRNSFinal Results
11th Nov 20107:00 amRNSAppointment of Broker
1st Nov 20107:00 amRNSSecond Agreement with Sinclair Pharma
29th Sep 20105:05 pmRNSHolding(s) in Company
27th Sep 20102:51 pmRNSHolding(s) in Company
23rd Aug 20107:00 amRNSAgreement with Global Consumer Products Company
22nd Jun 20103:20 pmRNSDirectorate Change
22nd Apr 20107:00 amRNSAgreement with Sinclair Pharma plc
31st Mar 201011:25 amRNSResult of General Meeting
15th Mar 201011:08 amRNSProposed Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.